High-risk/high-reward preclinical, translational, and clinical CRC research RFP to speed cures; collaborations and public–private partnerships strongly encouraged; rolling submissions with rapid decisions.
Eligibility Criteria:
-
Open to academic, non-profit, and industry investigators with MD/PhD (or equivalent).
-
Multiple mechanisms for early-career, senior, team science, pilot, and startup applicants.
Funding Details:
-
Young Investigator Accelerator: up to USD 100,000/year × 2 (max USD 200,000).
-
Senior Investigator Accelerator: up to USD 250,000/year × 2 (max USD 500,000).
-
Pilot Accelerator: up to USD 100,000/year × 2 (max USD 200,000).
-
Team Science Accelerator: up to USD 250,000/year × 2 (max USD 500,000).
-
Opportunistic (startups): up to USD 500,000 (1 year).
-
Indirect costs may be allowed up to 5% on a case-by-case basis.
Deadline:
-
Rolling call: applications accepted starting January 25; decisions typically within ~2 months of submission.
Where to Go for Further Information:
-
Apply via ProposalCentral (Project Cure CRC).
-
Program contacts: [email protected]; [email protected].